Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.160
+0.020 (0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $266.90 million as of November 21, 2024. Its market cap has decreased by -4.47% in one year.
Market Cap
266.90M
Enterprise Value
-214.07M
1-Year Change
-4.47%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $266.90M, a decrease of -86.23%. That is a compound annual growth rate of -38.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 266.90M | 4.88% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 279.88M |
| OraSure Technologies | 279.73M |
| AngioDynamics | 279.56M |
| Rezolute | 272.37M |
| Accolade | 272.22M |
| NeuroPace | 267.14M |
| Ocugen | 265.45M |
| Mersana Therapeutics | 260.65M |